dupilumab
sanofi,regeneron
['dupilumab']
new #jitc short report: management of immune-related cutaneous adverse events with dupilumab #asco23 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)